{"id":"https://openalex.org/W2741746058","doi":"https://doi.org/10.1158/1538-7445.am2017-1704","title":"Abstract 1704: UPR signaling promotes T-cell dysfunction to prevent immune-mediated cancer cell killing and immune checkpoint therapy resistance","display_name":"Abstract 1704: UPR signaling promotes T-cell dysfunction to prevent immune-mediated cancer cell killing and immune checkpoint therapy resistance","publication_year":2017,"publication_date":"2017-07-01","ids":{"openalex":"https://openalex.org/W2741746058","doi":"https://doi.org/10.1158/1538-7445.am2017-1704","mag":"2741746058"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2017-1704","doi":"https://doi.org/10.1158/1538-7445.am2017-1704","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2017-1704","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083838918","display_name":"Yismeilin R. Feliz\u2010Mosquea","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I47251452","display_name":"Wake Forest University","ror":"https://ror.org/0207ad724","country_code":"US","type":"education","lineage":["https://openalex.org/I47251452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yismeilin R. Feliz Mosquea","raw_affiliation_strings":["Wake Forest University, Winston Salem, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wake Forest University, Winston Salem, NC","institution_ids":["https://openalex.org/I47251452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110676306","display_name":"David R. Soto Pantoja","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I47251452","display_name":"Wake Forest University","ror":"https://ror.org/0207ad724","country_code":"US","type":"education","lineage":["https://openalex.org/I47251452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David R. Soto Pantoja","raw_affiliation_strings":["Wake Forest University, Winston Salem, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wake Forest University, Winston Salem, NC","institution_ids":["https://openalex.org/I47251452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102743760","display_name":"Adam S. Wilson","orcid":"https://orcid.org/0009-0001-8408-7478","observed_orcids":["https://orcid.org/0009-0001-8408-7478"]},"institutions":[{"id":"https://openalex.org/I47251452","display_name":"Wake Forest University","ror":"https://ror.org/0207ad724","country_code":"US","type":"education","lineage":["https://openalex.org/I47251452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adam Wilson","raw_affiliation_strings":["Wake Forest University, Winston Salem, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wake Forest University, Winston Salem, NC","institution_ids":["https://openalex.org/I47251452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087285442","display_name":"Pierre L. Triozzi","orcid":"https://orcid.org/0000-0003-2488-6136","observed_orcids":["https://orcid.org/0000-0003-2488-6136"]},"institutions":[{"id":"https://openalex.org/I47251452","display_name":"Wake Forest University","ror":"https://ror.org/0207ad724","country_code":"US","type":"education","lineage":["https://openalex.org/I47251452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pierre L. Triozzi","raw_affiliation_strings":["Wake Forest University, Winston Salem, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wake Forest University, Winston Salem, NC","institution_ids":["https://openalex.org/I47251452"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025967603","display_name":"Katherine Loree Cook","orcid":"https://orcid.org/0000-0001-6241-0214","observed_orcids":["https://orcid.org/0000-0001-6241-0214"]},"institutions":[{"id":"https://openalex.org/I47251452","display_name":"Wake Forest University","ror":"https://ror.org/0207ad724","country_code":"US","type":"education","lineage":["https://openalex.org/I47251452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katherine L. Cook","raw_affiliation_strings":["Wake Forest University, Winston Salem, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wake Forest University, Winston Salem, NC","institution_ids":["https://openalex.org/I47251452"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I47251452"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"77","issue":"13_Supplement","first_page":"1704","last_page":"1704"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8705999851226807,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8705999851226807,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11150","display_name":"Endoplasmic Reticulum Stress and Disease","score":0.12319999933242798,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/unfolded-protein-response","display_name":"unfolded protein response","score":0.9980000257492065},{"id":"https://openalex.org/keywords/endoplasmic-reticulum-stress","display_name":"endoplasmic reticulum stress","score":0.9470000267028809},{"id":"https://openalex.org/keywords/t-cell-exhaustion","display_name":"T cell exhaustion","score":0.9919999837875366},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-resistance","display_name":"immune checkpoint inhibitor resistance","score":0.7549999952316284},{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":0.8640000224113464},{"id":"https://openalex.org/keywords/perk","display_name":"PERK","score":0.9520000219345093},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.656000018119812},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.7799999713897705},{"id":"https://openalex.org/keywords/cytotoxic-t-lymphocytes","display_name":"cytotoxic T lymphocytes","score":0.7229999899864197},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.7789999842643738},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.6779999732971191},{"id":"https://openalex.org/keywords/perk-inhibition","display_name":"PERK inhibition","score":0.7139999866485596},{"id":"https://openalex.org/keywords/tumor-immune-evasion","display_name":"tumor immune evasion","score":0.5149999856948853}],"concepts":[{"id":"https://openalex.org/C139447449","wikidata":"https://www.wikidata.org/wiki/Q14633900","display_name":"Unfolded protein response","level":3,"score":0.812694787979126},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.6335045695304871},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6331132650375366},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.615436851978302},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4926963150501251},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4853990972042084},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.48191407322883606},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.4543265104293823},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.4457356929779053},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.44374144077301025},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4398716390132904},{"id":"https://openalex.org/C2777877232","wikidata":"https://www.wikidata.org/wiki/Q17144704","display_name":"Immunogenic cell death","level":4,"score":0.429922491312027},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4005107283592224},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.34567755460739136},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3130794167518616},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.2689611315727234},{"id":"https://openalex.org/C158617107","wikidata":"https://www.wikidata.org/wiki/Q79927","display_name":"Endoplasmic reticulum","level":2,"score":0.2632043957710266},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.13359785079956055},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2017-1704","doi":"https://doi.org/10.1158/1538-7445.am2017-1704","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2017-1704","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9789000153541565}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4391377192","https://openalex.org/W2886241780","https://openalex.org/W4417274661","https://openalex.org/W4408253781","https://openalex.org/W4308376803","https://openalex.org/W2945426048","https://openalex.org/W4296663008","https://openalex.org/W2576425501","https://openalex.org/W2073806920","https://openalex.org/W7124981335"],"abstract_inverted_index":{"Abstract":[0],"A":[1],"critical":[2,76],"point":[3],"in":[4,54,284,322,366,387],"cancer":[5,182,243,266,294,417],"progression":[6],"is":[7,60,75,91,207],"evading":[8],"recognition":[9],"by":[10,18,39,130,282],"the":[11,46,67,104,125,323,429],"immune":[12,20,33,42,71,347,421],"system.":[13],"Cancer":[14,433,446],"cells":[15,326],"accomplish":[16],"this":[17],"stimulating":[19],"checkpoint":[21,34,43,72,422],"signals":[22],"on":[23],"effector":[24,318],"T-cells.":[25,233],"In":[26],"patients":[27,353,370],"with":[28,32,124,169,179,216,231,242,376],"advanced":[29,52],"melanoma":[30,53,185,191,325,352],"treated":[31],"inhibitors,":[35],"3-year":[36],"survival":[37],"increased":[38,126,198,362],"20%.":[40],"While":[41],"therapies":[44],"are":[45],"new":[47],"first":[48],"treatment":[49,261,355],"option":[50],"for":[51,173,432],"over":[55],"a":[56,153,159,218,286,308,382],"decade,":[57],"their":[58],"efficacy":[59],"limited":[61],"because":[62],"resistance":[63,74,360,373,424],"often":[64],"develops.":[65],"Understanding":[66],"molecular":[68],"mechanisms":[69],"of":[70,155,213,237,255,273,280,428],"inhibitor":[73],"to":[77,82,122,142,171,299,311,344,414],"develop":[78],"combinatorial":[79],"drug":[80],"therapy":[81,359,389,423],"potentiate":[83],"therapeutic":[84,342],"responsiveness.":[85],"The":[86],"unfolded":[87],"protein":[88,127],"response":[89],"(UPR)":[90],"an":[92,197,340],"endoplasmic":[93],"reticulum":[94],"(ER)":[95],"stress":[96,257,275],"pathway":[97],"activated":[98,208],"when":[99,297,374],"unfolded/misfolded":[100],"proteins":[101],"accumulate":[102],"within":[103],"ER.":[105],"Highly":[106],"secretory":[107],"cell":[108,116,132,136,186,192,267,295,418],"types,":[109],"such":[110],"as":[111,152],"T-cells,":[112],"have":[113],"larger":[114],"ER":[115,143,223,256,274,300],"compartments":[117],"and":[118,176,200,228,420],"elevated":[119,148],"UPR":[120,149,205,250,363,385,409],"components":[121,151,365],"deal":[123],"synthesis/folding":[128],"required":[129],"these":[131,135],"types.":[133],"Therefore,":[134],"types":[137],"may":[138,306,338],"be":[139,339],"highly":[140],"sensitive":[141],"stress.":[144],"Our":[145],"data":[146],"demonstrates":[147],"signaling":[150,206,364,386,410],"driver":[154],"T-cell":[156,162,210,249,264,277,289,292,313,317,412],"exhaustion/dysfunction.":[157],"Using":[158],"previously":[160],"established":[161],"exhaustion":[163,314],"protocol,":[164],"we":[165],"stimulated":[166],"na\u00efve":[167,214],"T-cells":[168,195,215,238],"antibodies":[170],"CD3/CD28":[172,246],"5":[174],"days":[175],"co-cultured":[177],"them":[178],"MDA-MB-231":[180],"breast":[181],"cells,":[183,244],"Mun2b":[184],"line,":[187,290],"or":[188,315,356],"CMI":[189],"patient-derived":[190,324],"line.":[193],"Exhausted":[194],"displayed":[196],"PD-1":[199,227],"PERK":[201,229,281,305,320,336],"expression,":[202],"suggesting":[203,303,333],"that":[204,221,240,304,334],"during":[209],"exhaustion.":[211,278],"Treatment":[212],"DTT,":[217],"chemical":[219],"agent":[220],"stimulates":[222],"stress,":[224],"also":[225],"induced":[226],"compared":[230,375],"vehicle-treated":[232],"Gene":[234],"expression":[235],"analysis":[236],"indicate":[239],"co-culture":[241],"not":[245,328],"activation,":[247],"elevates":[248],"gene":[251],"expression.":[252],"Furthermore,":[253],"induction":[254],"through":[258],"low-dose":[259],"DTT":[260],"decreased":[262],"cytotoxic":[263,288],"mediated":[265,293],"death,":[268],"further":[269],"supporting":[270,381],"our":[271],"hypothesis":[272],"inducing":[276],"Inhibition":[279],"RNAi":[283],"TALL-104,":[285],"human":[287],"enhanced":[291],"clearance":[296],"exposed":[298],"stress-inducing":[301],"agents,":[302],"represent":[307],"novel":[309,383],"target":[310],"prevent":[312,415],"restore":[316],"capabilities.":[319],"inhibition":[321,337],"did":[327],"negatively":[329],"affect":[330],"T-cell-mediated":[331],"killing,":[332],"systemic":[335],"effective":[341],"strategy":[343],"enhance":[345],"anti-tumor":[346],"responses.":[348],"Matched":[349],"PBMC":[350,367,377],"from":[351,369],"before":[354,379],"after":[357,371],"ipilimumab":[358,372],"indicated":[361],"samples":[368,378],"therapy,":[380],"role":[384],"anti-CTLA4":[388],"resistance.":[390],"Citation":[391],"Format:":[392],"Yismeilin":[393],"R.":[394,398],"Feliz":[395],"Mosquea,":[396],"David":[397],"Soto":[399],"Pantoja,":[400],"Adam":[401],"Wilson,":[402],"Pierre":[403],"L.":[404,407],"Triozzi,":[405],"Katherine":[406],"Cook.":[408],"promotes":[411],"dysfunction":[413],"immune-mediated":[416],"killing":[419],"[abstract].":[425],"In:":[426],"Proceedings":[427],"American":[430],"Association":[431],"Research":[434],"Annual":[435],"Meeting":[436],"2017;":[437],"2017":[438],"Apr":[439],"1-5;":[440],"Washington,":[441],"DC.":[442],"Philadelphia":[443],"(PA):":[444],"AACR;":[445],"Res":[447],"2017;77(13":[448],"Suppl):Abstract":[449],"nr":[450],"1704.":[451],"doi:10.1158/1538-7445.AM2017-1704":[452]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2017-08-08T00:00:00"}